Clementia raises $120M in IPO

On Aug. 2, bone disease company Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) raised $120 million through the sale of 8 million shares at $15 in an IPO underwritten by Morgan Stanley, Leerink, Wedbush...